As part of the collaboration, PeptiSystems will integrate the THESYS ACS Ergo synthesis column – developed by Asahi Kasei Bioprocess America for large-scale oligonucleotide production – into its large-scale peptide synthesis system, PeptiPro.

“With a proven and high-quality column integrated into our solution, we can offer a complete, turnkey solution that helps our customers accelerate development and reduce risk,” says Karin Granath, CEO of PeptiSystems. “It is a strategic step that strengthens our offering and supports future growth in both research and manufacturing.”